Apex Drugs Limited - Company Profile

It is a pharma public limited company based in Jinnaram, Telangana, India, established in 1989.
1989 Jinnaram, Telangana, India Active
Last Updated:
Access Report
About Apex Drugs Limited

Apex Drugs Limited, a active public limited company, was established on 05 December 1989 in Jinnaram, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1989PLC010737. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹2.00 Cr.

Formerly known as Apex Drugs And Intermediates Limited. It upholds a compliant status. Employing 31 professional, Its leadership includes Gajanana Kudva (Director), Kajal Kiran Damania (Director), Shankar Sitaram Dige (Cfo). Past directors included Vilas Ramkrishna Lokhande, Ghanshyam Surajbali Kurmi, Kunal Nand Rohra. It holds no open charges and ₹135.21 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Survey No.14 Gaddapotharam, Jinnaram, Telangana, 502319.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1989PLC010737

  • Registration Number

    010737

  • Incorporation Date

    05 December 1989

  • Authorized Capital

    ₹25.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 36 Year, 3 Months
  • Last Filing with ROC 31 Mar 2022
  • Satisfied Charges ₹ 135.21 Cr
  • Revenue Growth **** %
  • Net Worth 101.50%
  • Total Assets -91.30%
Company report

Apex Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Apex Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Apex Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Gajanana Kudva Director 29 Aug 2020 Current
Kajal Kiran Damania Director 28 Aug 2020 Current
Shankar Sitaram Dige Cfo 15 Sep 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 05 Feb 2015 Past
Pramod Abcsdd Whole-Time Director 01 Jun 2011 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 14 Jan 2021 Past
Pramod Abcsdd Additional Director 11 Jul 2019 Past
Pramod Abcsdd Additional Director 01 Mar 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Apex Drugs.

Apex Drugs Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 101.5%.

Apex Drugs revenue growth over time
Apex Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -91.30%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 101.50%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Apex Drugs?

In 2022, Apex Drugs had a promoter holding of 99.94% and a public holding of 0.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,352,114,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 70.53 Cr
  • Bank Of India : 23.85 Cr
  • Icici Bank Limited : 22.20 Cr
  • Allahabad Bank : 16.00 Cr
  • Oriental Bank Of Commerce : 1.56 Cr
  • Others : 1.07 Cr
Latest Charge Details
Date Lender Amount Status
01 Dec 2010 Allahabad Bank ₹16.00 Cr Satisfied
12 Sep 2008 Bank Of India ₹23.85 Cr Satisfied
23 Apr 2007 Icici Bank Limited ₹22.20 Cr Satisfied
24 Feb 2003 State Bank Of India ₹3.50 Cr Satisfied
24 Feb 2003 State Bank Of India ₹66.54 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Apex Drugs?

Unlock and access historical data on people associated with Apex Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Apex Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Apex Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Apex Drugs Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Apex Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was completed.

  • Charges

    Progress on A charge registered on 01 Dec 2010 via Charge ID 10254676 with Allahabad Bank was fully satisfied on 15 Sep 2021. was documented.

  • Charges

    Progress on A charge registered on 12 Sep 2008 via Charge ID 10124609 with Bank Of India was fully satisfied on 15 Sep 2021. was documented.

  • Director Appointment

    Progress on Shankar Sitaram Dige was appointed as a CFO was appointed as a CFO on 15 Sep 2021 & has been associated with this company since 4 years 6 months . was documented.

  • Director Appointment

    Progress on Shankar Sitaram Dige was appointed as a CFO was appointed as a CFO on 15 Sep 2021 & has been associated with this company since 4 years 6 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Apex Drugs Limited?

The CIN of Apex Drugs Limited is U24230TG1989PLC010737.

Where is Apex Drugs Limited headquartered?

Apex Drugs Limited is headquartered at Survey No.14 Gaddapotharam, Jinnaram, Telangana, 502319.

When was Apex Drugs Limited incorporated?

Apex Drugs Limited was incorporated on 05 December 1989.

Who are the current directors of Apex Drugs Limited?

The current directors of Apex Drugs Limited are

What is the primary industry of Apex Drugs Limited?

The primary industry of Apex Drugs Limited is Manufacturing.

Is Apex Drugs Limited a listed company?

Apex Drugs Limited is unlisted.

What is the capital structure of Apex Drugs Limited?

The authorized capital of Apex Drugs Limited is ₹25.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Apex Drugs Limited?

The compliance status of Apex Drugs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available